Medical News

Tennessee: Vanderbilt University Seeks More Men for HIV Vaccine Trial

November 14, 2011

Vanderbilt University has signed up 70 HIV-negative men who have sex with men for its part in a national HIV vaccine trial and now is looking to enroll more. Researchers have boosted their nationwide enrollment goal for the HVTN 505 trial from 1,350 to 2,200. The trial was conceived to study whether the vaccine could lower viral load in those infected; the expansion reflects scientists' desire to determine whether the vaccine can significantly reduce the number of new infections. For more information on how to volunteer, telephone 615-322-HOPE (4673) or visit

Back to other news for November 2011

Adapted from:
The Tennessean (Nashville)
10.19.2011; Tom Wilemon

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.